An IAEA researcher collects samples from the Antarctic shoreline. (Image: IAEA)
The International Atomic Energy Agency, in cooperation with Argentina, launched a scientific research expedition on January 6 to study microplastics in Antarctica—one of the planet’s most remote areas—as part of an effort to combat widespread microplastic pollution.
Concept art of the Chalk River near surface disposal facility for LLW. (Image: CNL)
The Canadian Nuclear Safety Commission has decided to amend Canadian Nuclear Laboratories’ operating license for the Chalk River Laboratories, allowing the construction of a near surface disposal facility (NSDF) for low-level radioactive waste on the nuclear research site in Deep River, Ontario.
Urenco UK’s Capenhurst enrichment site, which received a grant in July 2023 to prepare for HALEU enrichment. (Photo: Urenco UK)
The United Kingdom’s Department for Energy Security and Net Zero announced plans on January 7 to invest £300 million (about $383 million) to build a high-assay low-enriched uranium (HALEU) enrichment facility in northwest England. The goal? To “end Russia’s reign as the only commercial producer of HALEU.” Britain is now the first European country to declare that it will begin HALEU enrichment in a bid for supply chain security.
Heysham-1 nuclear power plant and visitors center. (Photo: EDF)
French energy supplier Électricité de France announced this week it will invest $1.7 billion to keep its U.K. fleet in production through 2026.
Oak Ridge crews will begin demolition of the 325,000-sqaure-foot Alpha-2 facility this year, marking the first teardown of a former uranium enrichment facility at Y-12. (Photo: DOE)
The Department of Energy announced that its Oak Ridge Office of Environmental Management (OREM) is moving ahead with a slate of projects this year that will alter the Tennessee site’s skyline, remove inventories of nuclear waste, and complete a major phase of cleanup.
Bavarian minister of state Florian Herrmann (left) with ITM CEO Steffen Schuster (right) and others at a mock-up Lu-177 hot cell. (Photo: ITM)
Radiopharmaceutical biotech company ITM Isotope Technologies Munich announced it has received regulatory approval to begin production of the medical radioisotope lutetium-177 at the company’s NOVA facility in Neufahrn, near Munich, Germany.